Why the study?
Does acetylsalicylic acid prevent vascular events in primary and secondary prevention populations?
Does acetylsalicylic acid prevent vascular events in primary and secondary prevention populations?
This guideline updates clinical practice by strongly recommending against the routine use of acetylsalicylic acid for the primary prevention of vascular events, while reaffirming its critical role in secondary prevention.
Answers are grounded in this paper and cite their sources.
Deprescribe acetylsalicylic acid for primary prevention to reduce bleeding; challenges prior broad use while reinforcing secondary prevention.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Wein et al. (2020) conducted a review in Vascular events (cardiovascular, cerebrovascular, peripheral arterial disease). Acetylsalicylic acid vs. No acetylsalicylic acid was evaluated. Acetylsalicylic acid is strongly recommended for secondary prevention of vascular events but is no longer recommended for routine primary prevention due to bleeding risks potentially outweighing benefits.
Synapse has enriched 10 related papers. Consider them for comparative context: